-

Fewer Biopsies, Better Accuracy: How AI Is Reshaping TI-RADS and BI-RADS Reporting

AI is converging with TI-RADS and BI-RADS in ways that go beyond automation. Inside how structured reporting is reducing unnecessary biopsies, improving consistency, and reclaiming clinical time, and what it means for the data infrastructure powering what comes next.

  • AI
  • Radiology
  • Reporting

Inside the convergence of structured frameworks and artificial intelligence, and what it means for radiology workflow, consistency, and the data powering what comes next.

When the ACR published BI-RADS in 1992, the goal was straightforward: give radiologists a shared language for breast imaging findings. TI-RADS followed with the same logic for thyroid nodules; a points-based system to replace subjective assessments with structured, reproducible classifications.

These frameworks worked. They standardized communication, reduced ambiguity, and gave clinical teams a common basis for management decisions. But they were designed for human application: examine an image, identify features, assign a score, document a recommendation. The framework was, in essence, a checklist.

That is changing. With 873 FDA-cleared radiology AI algorithms as of mid-2025, artificial intelligence is converging with RADS frameworks in ways that go beyond automation. The question is no longer whether AI belongs in the imaging workflow. It is whether the reporting infrastructure is ready for it.

What AI and Structured Reporting Solve Together

Even with established frameworks, human readers apply criteria inconsistently. Variability in assigning sonographic features, particularly margin characteristics and echogenicity, leads to different TI-RADS classifications for the same nodule depending on who reads it. BI-RADS density assessment introduces similar variability. The lexicon is sound. The application is variable.

AI changes the equation by sharpening the RADS frameworks at every stage of the reporting workflow.

Reducing unnecessary biopsies. Before structured risk stratification, fine-needle aspiration rates for detected thyroid nodules were reported as high as 61.9%. ACR TI-RADS reduced unnecessary biopsies by 19.9 to 46.5% compared to other systems. But layer AI on top and the gains compound: one study found that AI-assisted TI-RADS classification cut unnecessary fine-needle aspiration rates from 47.8% to 41.0% while simultaneously improving the missed cancer rate. Fewer procedures, better outcomes.

Improving diagnostic consistency. A 2024 study in Thyroid found that AI decision support improved diagnostic accuracy across readers with varying levels of experience. Deep learning models have achieved over 89% accuracy in automated BI-RADS density classification. The frameworks give AI the structured architecture it needs; AI gives the frameworks the consistency they have always sought.

Reclaiming clinical time. A 2025 study in JAMA Network Open, conducted across 11 hospitals, found that AI-assisted structured reporting improved average documentation efficiency by 15.5%, with some radiologists achieving gains as high as 40%, without compromising accuracy or quality. At a time when 43% of radiologists report spending more time on admin than patient care, that gain is not incremental. It is directional.

The Platform Beneath the Framework

Approval pace has significantly outrun integration standards. The bottleneck is not whether AI can classify a thyroid nodule or assess breast density; it is whether that classification seamlessly flows into a structured report, an audit trail, or a registry submission within the existing workflow.

This is where structured reporting platforms become essential. A platform like KailoFlow, which enforces lexicon-consistent fields (echogenicity, margins, and composition for TI-RADS; density and mass descriptors for BI-RADS), serves as both the destination for AI-generated outputs and the infrastructure they require to be clinically actionable: the audit trail, the quality framework, and the interoperability layer connecting findings to the clinical record.

From Reports to Data Assets

Practices generating clean, RADS-coded structured data are building an asset that extends beyond the individual report; ACR registry participation, HEDIS and MIPS quality reporting, and the training datasets future AI models will require. BI-RADS has already been cited as foundational infrastructure for multi-centre AI development, enabling consistent labelling across institutions and geographies.

AI-powered dictation tools like KailoAir are beginning to close the loop: voice in, structured RADS-compliant data out. Combined with a structured template architecture, these tools help practices capture the efficiency gains documented by the research while building the data foundation on which everything downstream depends.

The Checkpoint Became the Foundation

When RADS frameworks were introduced, they solved a communication problem. What recent clinical data have shown is that they also laid the groundwork for something larger. AI-assisted structured reporting is reducing unnecessary biopsies, improving diagnostic consistency across experience levels, and returning meaningful time to clinical work; measured outcomes from peer-reviewed, multi-site studies.

The practices that benefit most will be those with a reporting infrastructure that is already structured, interoperable, and ready to serve as the integration layer between AI tools and the clinical record. The checkbox became an intelligence layer. The foundation it sits on is what determines whether that intelligence reaches the patient.


Sources & Citations: Statistics referenced in this article are drawn from published peer-reviewed research, including: Middleton et al., AJR Special Series; Cui et al., J Ultrasound Med 2023; Huang et al., JAMA Network Open 2025; Fernandez Velasco et al., Thyroid 2024; European Radiology 2024; Philips Future Health Index 2025; FDA clearance data via IntuitionLabs 2025.